abrdn Life Sciences Investors (HQL) vs Nuveen Global High Income Fund (JGH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 9.6x for Nuveen Global High Income Fund). abrdn Life Sciences Investors pays a dividend yielding 11.13%, while Nuveen Global High Income Fund does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | HQL | JGH |
|---|---|---|
| Share price | $17.16 | $11.50 |
| Market cap | — | $323.31M |
| 1-day change | -2.27% | -0.39% |
| YTD return | +4.65% | — |
| 1-year return | +11.21% | — |
| 5-year return | -15.00% | — |
| P/E ratio (TTM) | 2.58 | 9.58 |
| EPS (TTM) | $6.64 | $1.20 |
| Dividend yield | 11.13% | 10.76% |
| Annual dividend | $1.91 | $0.00 |
| 52-week high | $22.67 | $13.45 |
| 52-week low | $15.66 | $11.38 |
| Distance from 52-week high | -24.30% | -14.54% |
| Average volume | 147.31K | 77.82K |
| Shares outstanding | — | 28.13M |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nuveen Global High Income Fund trades at a higher earnings multiple (9.6x vs 2.6x trailing P/E).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
About Nuveen Global High Income Fund
JGH stock →Nuveen Global High Income Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.
Finance · Investment Managers
HQL vs JGH FAQ
Which has the lower P/E ratio, HQL or JGH?
HQL has the lower trailing P/E at 2.6, versus 9.6 for JGH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Nuveen Global High Income Fund?
abrdn Life Sciences Investors has the higher yield at 11.13%, compared with 10.76% for Nuveen Global High Income Fund.
Are abrdn Life Sciences Investors and Nuveen Global High Income Fund in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.